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Immunogenetics is the science that studies the genetics of the immune system and
immune responses. Owing to the complexity and diversity of the immune repertoire,
immunogenetics represents one of the greatest challenges for data interpretation: a large
biological expertise, a considerable effort of standardization and the elaboration of an efﬁ-
cient system for the management of the related knowledge were required. IMGT®, the
international ImMunoGeneTics information system® (http://www.imgt.org) has reached
that goal through the building of a unique ontology, IMGT-ONTOLOGY, which represents
the ﬁrst ontology for the formal representation of knowledge in immunogenetics and
immunoinformatics. IMGT-ONTOLOGY manages the immunogenetics knowledge through
diverse facets that rely on the seven axioms of the Formal IMGT-ONTOLOGY or IMGT-
Kaleidoscope: “IDENTIFICATION,” “DESCRIPTION,” “CLASSIFICATION,” “NUMEROTA-
TION,” “LOCALIZATION,” “ORIENTATION,” and “OBTENTION.” The concepts of identi-
ﬁcation, description, classiﬁcation, and numerotation generated from the axioms led to
the elaboration of the IMGT® standards that constitute the IMGT Scientiﬁc chart: IMGT®
standardizedkeywords(conceptsofidentiﬁcation),IMGT® standardizedlabels(conceptsof
description), IMGT® standardized gene and allele nomenclature (concepts of classiﬁcation)
and IMGT unique numbering and IMGT Collier de Perles (concepts of numerotation). IMGT-
ONTOLOGY has become the global reference in immunogenetics and immunoinformatics
for the knowledge representation of immunoglobulins (IG) or antibodies, T cell receptors
(TR), and major histocompatibility (MH) proteins of humans and other vertebrates, proteins
of the immunoglobulin superfamily (IgSF) and MH superfamily (MhSF), related proteins of
the immune system (RPI) of vertebrates and invertebrates, therapeutic monoclonal anti-
bodies (mAbs), fusion proteins for immune applications (FPIA), and composite proteins for
clinical applications (CPCA).
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INTRODUCTION
Immunogenetics is the science that studies the genetics of the
immune system and immune responses. Among them, the adap-
tive immune response, acquired by vertebrates with jaws or
gnathostomata,is characterized by an extreme diversity of the spe-
ciﬁcantigenreceptorsthatcomprisetheimmunoglobulins(IG)or
antibodies and the T cell receptors (TR). The potential repertoire
of each individual is estimated to comprise about 2×1012 differ-
entIGandTR,andthelimitingfactorisonlythenumberof Band
T cells that an organism is genetically programmed to produce.
This huge diversity results from the complex and unique mole-
cular synthesis and genetics of the antigen receptor chains that
includeDNAmolecularrearrangements(combinatorialdiversity)
in multiple loci (three for IG and four for TR in humans) located
on different chromosomes (four in humans),nucleotide deletions
and insertions at the rearrangement junctions (or N-diversity)
and, for the IG, somatic hypermutations (for review see Lefranc
and Lefranc, 2001a,b).
Owing to the complexity and diversity of the immune reper-
toiresandtheirimplicationsinfundamentalandmedicalresearch,
immunogenetics represents one of the greatest challenges for data
interpretation:a large biological expertise,a considerable effort of
standardization and the elaboration of an efﬁcient system for the
management of the related knowledge were required. To answer
thatchallenge,IMGT®,theinternationalImMunoGeneTicsinfor-
mation system® (http://www.imgt.org) was created in 1989 by the
Laboratoire d’ImmunoGénétique Moléculaire LIGM (Université
Montpellier 2 and CNRS) at Montpellier, France (Lefranc et al.,
2009; Lefranc, 2011a). IMGT® has become the global reference
in immunogenetics and immunoinformatics. IMGT® is a high-
quality integrated knowledge resource that provides a common
access to standardized data from genome, proteome, genetics,
two-dimensional (2D) and three-dimensional (3D) structures. It
comprises 7 databases (sequence, gene, structure and specialist
databases), 17 online tools and more than 15,000 pages of web
resources (Lefranc et al., 2009).
IMGT® has reached that goal through the building of a unique
ontology, IMGT-ONTOLOGY started in 1989 and, since then,
in constant evolution and extension (Giudicelli and Lefranc,
1999; Lefranc et al., 2004, 2005a, 2008; Duroux et al., 2008;
Lefranc, 2011b,c,d,e,f, 2013). IMGT-ONTOLOGY represents the
ﬁrst ontology for the formal representation of knowledge in
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immunogenetics and immunoinformatics. IMGT-ONTOLOGY
manages the immunogenetics knowledge through diverse facets
that rely on the seven axioms of the Formal IMGT-ONTOLOGY
or IMGT-Kaleidoscope: “IDENTIFICATION,”“DESCRIPTION,”
“CLASSIFICATION,” “NUMEROTATION,” “LOCALIZATION,”
“ORIENTATION,” and “OBTENTION” (Duroux et al., 2008).
These axioms postulate that any object, any process and any rela-
tionhastobeidentiﬁed,described,classiﬁed,numbered,localized,
and orientated, and that the way it is obtained can be charac-
terized. The IMGT-ONTOLOGY concepts were generated from
these axioms. The concepts of identiﬁcation, description, classi-
ﬁcation, and numerotation led to the elaboration of the IMGT®
standards that constitute the IMGT Scientiﬁc chart: IMGT® stan-
dardized keywords (concepts of identiﬁcation),IMGT® standard-
ized labels (concepts of description),IMGT® standardized IG and
TR gene and allele nomenclature (concepts of classiﬁcation) and
IMGT unique numbering and IMGT Collier-de-Perles (concepts
ofnumerotation).OnemajorfeatureofIMGT-ONTOLOGYisthe
formalizationofthespeciﬁcrelationsthatlink,onasemanticpoint
of view, the different concepts and capture the immunogenetics
complexity. These relations are fundamental for data consistency
and biological interpretation.
MATERIALS AND METHODS
An ontology is deﬁned as “an explicit speciﬁcation of a concep-
tualization”(Gruber, 1993; Guarino and Giaretta, 1995; Guarino,
1997). The building of IMGT-ONTOLOGY has consisted in the
conceptualization and in the formalization of the related knowl-
edge in immunogenetics, and in the deﬁnition of the relations
between concepts. The ﬁrst concepts were deﬁned as “relevant
and fundamental criteria which are needed to characterize IG and
TR data” (Giudicelli and Lefranc, 1999). Since then, the IMGT-
ONTOLOGY concepts have been largely extended to molecular
components other than IG and TR, that include major histo-
compatibility (MH) proteins of humans and other vertebrates,
proteins of the immunoglobulin superfamily (IgSF), and MH
superfamily(MhSF),relatedproteinsof theimmunesystem(RPI)
of vertebratesandinvertebrates,therapeuticmonoclonalantibod-
ies (mAbs), fusion proteins for immune applications (FPIA), and
composite proteins for clinical applications (CPCA).
Concepts are characterized by their properties which may be
simple attributes or relations between concepts. The relation of
subsumption (is_a) allows to structure the IMGT-ONTOLOGY
concepts, and to represent them as nodes of the graph with their
level of granularity. The concepts that correspond to the ﬁnest
levelof granularity(andthehighestlevelof precision)inbranches
of thegrapharedesignatedas“leafconcept.”Conceptsfromwhich
a hierarchy is generated with several levels before reaching the
leafconcepts are designated as“highconcept.”
IMGT-ONTOLOGY is being formalized in OWL-DL1 lan-
guage using the Protégé editor2 (Noy et al.,2003). The formalized
concepts of identiﬁcation are available for downloading or brows-
ing on the National Center for Biomedical Ontology (NCBO)
1http://www.w3.org/TR/owl2-overview/
2http://protege.stanford.edu
BioPortal3 (Noyetal.,2009;Musenetal.,2012)andontheIMGT®
web site (http://www.imgt.org; Lefranc, 2011a,b,c,d,e,f).
The semantic relations (other than subsumption) are for-
malized as OWL object properties (see OWL 2 Web Ontology
Languagehttp://www.w3.org/TR/owl-primer/):Objectproperties
allowtolinkspeciﬁcallytwoconceptsthroughthestatement“Sub-
ject>Property>Object” where “Subject” is the concept being
characterized by the object property, “Property” the name of a
given property deﬁned in the ontology and“Object”the name of
the concept that is linked. These properties are restricted using
in particular universal quantiﬁcation (all connected individuals
by the property must be instances of a given class), existential
quantiﬁcation (all individuals of the class for which the prop-
erty is deﬁned are connected to at least one individuals of the
class mentioned in the restriction) and cardinality restrictions
(quantiﬁcation of the number of connected individual with the
property).TheserelationscanbedisplayedonNCBOBioPortalin
“IMGT-ONTOLOGY>Terms >Details”page.Theyareindicated
in the “Equivalent Class” section if they are necessary and sufﬁ-
cient to deﬁne the concept,or in the“Sub Class Of”section if they
are necessary only (for instance,the relations“is_deﬁned_by”and
“_has_” of the “D-gene” (which is a “Molecule_EntityType” leaf-
concept,seebelow“Molecule_EntityType”Concept),areexamples
of relations in “Equivalent Class” and “Sub Class Of” sections,
respectively). The formalization of these relations highlights and
focuses on the dependencies between the terms that are closely
interconnected at the level of immunogenetics knowledge and set
up the constraints that must be respected in the IMGT® databases
and tools and in immunoinformatics.
RESULTS
IMGT-ONTOLOGY IDENTIFICATION AXIOM
TheIDENTIFICATIONaxiomoftheFormalIMGT-ONTOLOGY
or IMGT-Kaleidoscope (Duroux et al., 2008) postulates that, for
molecular components, any molecule and its relations have to be
identiﬁed(Lefranc,2011b).IMGT-ONTOLOGYconceptsofiden-
tiﬁcation generated from the IDENTIFICATION axiom led to the
IMGT® standardized keywords for molecular components (IG,
TR, MH, RPI, FPIA, and CPCA) in IMGT® databases and tools.
IMGT-ONTOLOGY concepts of identiﬁcation
“Molecule_EntityType” concept. The objective of IMGT-
ONTOLOGY was to identify the type of any molecular entity at
each step of its synthesis. An insight of the knowledge related to
the synthesis of an IG is schematized in Figure 1. It illustrates the
concept of “Molecule_EntityType”and the other related concepts
of identiﬁcation and the relations that link them.
The“Molecule_EntityType”conceptisfullydeﬁnedbythecon-
cepts of “MoleculeType,” “GeneType,” and “ConﬁgurationType”
(Figure 2).
– “MoleculeType” allows one to identify the type of molecule,
based on the type of the constitutive elements and on the con-
ceptsof obtention.The“MoleculeType”conceptcomprisesfour
major leafconcepts:“gDNA,”“mRNA,”“cDNA,”“protein.”
3http://bioportal.bioontology.org/ontologies/1491
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FIGURE 1 |An example of knowledge at the molecular level: the
synthesis of an IG or antibody in humans, described in (Lefranc,
2011a). “gDNA,” “mRNA,” and “protein” are types of molecules
(“MoleculeType”) that are involved in the IG orTR synthesis, “germline”
and “rearranged” are types of conﬁguration (“ConﬁgurationType”) [the
conﬁguration of C-gene is “undeﬁned” (not shown)]. A molecule entity
type characterizes a unique conformation of a molecular component at
each step of its biosynthesis, which is deﬁned by a type of molecule, a
type of conﬁguration and type(s) of genes.The 10 leafconcepts of
“Molecule_EntityType” identiﬁed during the IG synthesis (e.g., V-gene,
V-D-J-gene, L -V-D-J-C-sequence) are shown. Main steps of the antigen
receptor synthesis are indicated with numbers. (1) DNA rearrangements
(is_rearranged_into), (2)Transcription (is_transcribed_into), (3)Translation
(is_translated_into) (IMGT Repertoire, http://www.imgt.org).
– “GeneType” allows one to identify the type of gene. The
“GeneType”concept comprises six leafconcepts:“variable”(V),
“diversity” (D), “joining” (J), and “constant” (C) are the four
gene types speciﬁc of IG and TR, and “conventional-with-
leader,” “conventional-without-leader” are the two gene types
of conventional genes.
– “ConﬁgurationType” allows one to identify the type of con-
ﬁguration of a gene, and by extension, the type of conﬁgu-
ration of the Molecule_EntityType leafconcepts that contain
it. The “ConﬁgurationType” concept comprises four leafcon-
cepts:“germline,”“partially-rearranged”and“rearranged”forV,
D,and J genes and the molecule entities that contain them,and
“undeﬁned”for C and conventional genes and related entities.
The“Molecule_EntityType”conceptcomprises38leafconcepts
(Table 1). For examples, “V-gene” identiﬁes, for gDNA, mol-
ecule entities with a germline V gene, “V-D-J-gene” identiﬁes,
for gDNA, molecule entities with rearranged V, D, and J genes,
and “L-V-D-J-C-sequence” identiﬁes, for cDNA, molecule enti-
ties with rearrangedV,D,and J genes spliced toaCg e n e .T h ef o u r
“MoleculeUnit”leafconceptsthatare“gene”(10),“transcript”(11),
“sequence”(11),and“chain”(6) identify the type of entities based
on the“MoleculeType”only, as indicated by the sufﬁx (Table 1).
In addition to the relation “is_deﬁned_by,” a “Mole-
cule_EntityType” “has” properties identiﬁed in the “Functional-
ityType”and“StructureType”concepts (Figure 2).
– “FunctionalityType” is a concept of identiﬁcation that allows
one to identify, whatever the molecule type (gDNA, cDNA,
mRNA, or protein), the type of functionality of a Mole-
cule_EntityType leafconcept. The“FunctionalityType” concept
comprises ﬁve leafconcepts:“functional,”“ORF”(open reading
frame) and “pseudogene” identify the functionality of Mole-
cule_EntityType leafconcepts in undeﬁned conﬁguration (con-
ventional genes and IG and TR C genes), or in germline con-
ﬁguration (IG and TRV,D,and J genes before DNA rearrange-
ments); “productive” and “unproductive” identify the func-
tionality of Molecule_EntityType leafconcepts in rearranged
or partially-rearranged conﬁguration (IG and TR entities
after DNA rearrangements, and by extension fusion entities
resulting from translocations, and hybrid entities obtained by
biotechnology molecular engineering).
– “StructureType” is a concept of identiﬁcation that allows
one to identify, whatever the molecule type (gDNA, cDNA,
mRNA, protein), the type of structure of Molecule_EntityType
leafconcepts.
The semantic relations of “Molecule_EntityType” are formal-
ized as properties (in OWL).
“ChainType,” “DomainType,” and “ReceptorType” concepts.
One of the goals of IMGT-ONTOLOGY has been to repre-
sent knowledge in order to manage molecular components from
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FIGURE 2 |The “Molecule_EntityType” concept with its relations.
The “Molecule_EntityType” concept is deﬁned by the
“MoleculeType,” “GeneType,” and “ConﬁgurationType” concepts of
identiﬁcation and has properties identiﬁed in the “FunctionalityType”
and “StructureType” concepts (IDENTIFICATION axiom). Arrows
indicate reciprocal relations “is_deﬁned_by” and “deﬁnes,” “_has_,”
and “_for_.” Leafconcepts are general (online in blue) or speciﬁc of
the IG andTR (online in red).The “Molecule_EntityType” concept has
38 leafconcepts (or keywords in the IMGT® databases and tools).
Only a few examples of the “StructureType” leafconcepts (or
keywords in the IMGT® databases and tools) are shown (see details
in Lefranc, 2011b).
sequences to 3D structures in IMGT® databases and tools. The
three concepts “ChainType,”“DomainType,” and “ReceptorType”
have been fundamental in that knowledge representation.
“ChainType” is a concept of identiﬁcation that allows one to
identify the type of chain. “ChainType” is a “highconcept” that
comprises four levels (Figure 3): “MolecularComponentLevel-
ChainType,” “ReceptorLevelChainType,” “ClassLevelChainType,”
and “GeneLevelChainType.” The concepts are organized in an
acyclic graph based on the subsumption relation, the depth of
which depends on the precision that needs to (or that can be)
reported for the data identiﬁcation. The ﬁnest level of granularity,
the “GeneLevelChainType” concept, identiﬁes the type of chain
by reference to the gene(s) which code(s) the chain. It represents
the main concept for a very precise identiﬁcation because it estab-
lishes a relationship with “Gene” (concept of classiﬁcation) (the
reciprocal relations are: “is_coded_by” and “codes”). The num-
ber of “ChainType” leafconcepts of the “GeneLevelChainType”
depends on the number of functional genes and ORF (“Func-
tionalityType”)perhaploidgenome,inagivenspecies(inthecase
of the IG and TR genes,it is the number of functional and ORF C
genes which is taken into account).
The “ChainType” concept is deﬁned by the “Mole-
cule_EntityType”andthe“DomainType”conceptsofidentiﬁcation,
and also deﬁned by concepts of classiﬁcation (see IMGT-
ONTOLOGY CLASSIFICATION Axiom) as the type of chain
depends on the taxon (Figure 4). “DomainType” allows one to
identify the type of domain. A domain is a chain subunit char-
acterized by its three-dimensional (3D) structure, and by exten-
sion its amino acid sequence and the nucleotide sequence which
encodes it.
The“ChainType”concept represents a key concept that allows
to link the“Molecule_EntityType”(sequences in databases) to the
concept of“ReceptorType”(3D structures in databases;Figure4).
“ReceptorType”allowsonetoidentifythetypeofreceptor.“Recep-
torType”isdeﬁnedbythe“ChainType”leafconcept(s)thatidentify
the associated chains of a receptor.“ReceptorType”is a“highcon-
cept” with a hierarchy of four levels of granularity (depending
on the “ChainType” hierarchy). The “ReceptorType” concept has
properties identiﬁed in the “FormatType,”“SpeciﬁcityType,” and
“FunctionType”concepts (Figure 4; Lefranc, 2011b).
IMGT® standardized keywords in databases and tools
The leafconcepts of identiﬁcation are IMGT® standardized key-
words in the IMGT® databases and tools (Lefranc, 2005). The
list of IMGT® standardized keywords is available from the
IMGT/LIGM-DB database (Giudicelli et al., 2006) query page
(IMGT® Home page; http://www.imgt.org) and in the IMGT
Scientiﬁc chart at http://www.imgt.org/IMGTScientiﬁcChart/
SequenceDescription/IMGT3Dkeywords.html. More than 325
IMGT® standardized keywords (189 for sequences and 137 for
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Table 1 | “Molecule_EntityType” leafconcepts and related concepts.The 38 “Molecule_EntityType” leafconcepts are shown with the
leafconcepts of “GeneType,”“ConﬁgurationType,” and “MoleculeType” that deﬁne them.The four leafconcepts of “MoleculeUnit” are based on
“MoleculeType” only.
MoleculeUnit
leafconcepts
Molecule_EntityType
leafconcepts
GeneType
leafconcepts
ConﬁgurationType
leafconcepts
MoleculeType
leafconcepts
gene V-gene* V germline gDNA
D-gene* D
J-gene* J
J-C-gene J, C
C-gene* C undeﬁned
conventional-gene conventional
V-D-gene V, D partially-rearranged
D-J-gene D, J
V-J-gene* V, J rearranged
V-D-J-gene* V, D, J
transcript L -V-transcript V germline mRNA
D-transcript D
J-transcript J
J-C-transcript J, C
C-transcript C undeﬁned
L -nt-transcript conventional
nt-transcript conventional
L -V-D-transcript V, D partially-rearranged
D-J-C-transcript D, J, C
L -V-J-C-transcript V, J, C rearranged
L -V-D-J-C-transcript V, D, J, C
sequence L -V-sequence V germline cDNA
D-sequence D
J-sequence J
J-C-sequence J, C
C-sequence C undeﬁned
L -nt-sequence conventional
nt-sequence conventional
L -V-D-sequence V, D partially-rearranged
D-J-C-sequence D, J, C
L -V-J-C-sequence* V, J, C rearranged
L -V-D-J-C-sequence* V, D, J, C
chain L -AA-chain conventional undeﬁned Protein
AA-chain conventional
L -V-J-C-chain V, J, C rearranged
L -V-D-J-C-chain V, D, J, C
V-J-C-chain* V, J, C
V-D-J-C-chain* V, D, J, C
*Indicates the 10 leafconcepts that are the most classical representatives of IG andTR identiﬁcation.These leafconcepts are illustrated in Figure 1.
3D structures) were precisely deﬁned. They represent the con-
trolled vocabulary assigned during the annotation process and
allow standardized search criteria for querying the IMGT® data-
bases and for the extraction of sequences and 3D structures.
IMGT/HighV-QUEST, the IMGT® tool for analysis of IG and TR
nucleotide sequences obtained from next generation sequencing
(NGS;Alamyar et al.,2012),provides an evaluation of the conﬁg-
uration (“ConﬁgurationType”) and, accordingly, of the sequence
functionality(“FunctionalityType”):suchprecisionandstandard-
ization in the NGS results are of the utmost importance for the
reuse of data for the statistical analyses required for the compari-
son of immune repertoires (Prabakaran et al., 2012) and for data
interpretation.
IMGT-ONTOLOGY DESCRIPTION AXIOM
The DESCRIPTION axiom of the Formal IMGT-ONTOLOGY
or IMGT-Kaleidoscope (Duroux et al., 2008) postulates that,
for molecular components, any molecule and its relations have
to be described (Lefranc, 2011c). IMGT-ONTOLOGY concepts
of description generated from the DESCRIPTION axiom led
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FIGURE 3 | “ChainType” “highconcept.”The hierarchy of
“ChainType” for the identiﬁcation of IG chains comprises four levels of
granularity which are associated with an increasing level of precision:
the “MolecularComponentLevelChainType,” the
“ReceptorLevelChainType,” the “ClassLevelChainType,” and the
“GeneLevelChainType.”
to the IMGT® standardized labels for molecular components
(IG, TR, MH, RPI, FPIA, and CPCA) in IMGT® databases and
tools.
IMGT-ONTOLOGY concepts of description
Concepts of description have been progressively elaborated in
order to take into account the entities of the different steps of
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FIGURE 4 |The “ReceptorType” concept with its relations.The
“ReceptorType” concept is deﬁned by the “ChainType” concept of
identiﬁcation and has properties identiﬁed in the “FormatType” ,
“SpeciﬁcityType,” and “FunctionType” concepts (IDENTIFICATION axiom).
The “ChainType” concept is itself deﬁned by the “Molecule_EntityType”
and “DomainType” concepts and by concepts of classiﬁcation organized in
a hierarchy (see CLASSIFICATION axiom). Arrows indicate reciprocal
relations “is_deﬁned_by” and “deﬁnes,” “_has_,” and “_for_” (see details
in Lefranc, 2011b).The “ChainType” and “ReceptorType” concepts have
different levels of granularity (up to four) and are highconcepts.The
reciprocical relations between “ReceptorType” and “Cell_EntityType”
concepts are “_has_” and “_for_.”The “Cell_EntityType” (not developped
in the current version) is part of the “CellularComponent” concept
(Pappalardo et al., 2010).
the molecular synthesis of the antigen receptors (IG and TR) and,
more generally, of all molecular components and to describe all
motifsofbiologicalinterestofsequencesand2Dand3Dstructures
in databases and tools.
“Molecule_EntityPrototype” concept. The“Molecule_EntityPro
totype” is a concept, generated from the DESCRIPTION axiom,
that provides the description of the “Molecule_EntityType”
concept (IDENTIFICATION axiom). There are as many leaf-
concepts in the “Molecule_EntityPrototype” as there are leaf-
concepts in the “Molecule_EntityType.” Thus the “Mole-
cule_EntityPrototype”comprises38leafconceptsthatdescribethe
organization of each entity with its constitutive motifs and rela-
tions. Each “Molecule_EntityPrototype” leafconcept is linked to
a “Molecule_EntityType” leafconcept by the reciprocal relations
“describes” and “is_described_by.” For example, a “V-gene” is
described by “V-GENE,” and a “V-D-J-gene” by “V-D-J-GENE.”
Leafconcepts of description (labels in the IMGT® databases and
tools) are written in capital letters.
Prototypes and relations between concepts of description. In
order to visualize the organization of each entity,prototypes were
deﬁned. A prototype is a graphical representation of a “Mole-
cule_EntityPrototype”leafconcept. Two prototypes of “V-GENE”
and “V-D-J-GENE” are shown in Figure 5 as examples of a
germline entity and of a rearranged entity, respectively. Twenty-
seven labels for “V-GENE” and 33 labels for “V-D-J-GENE” (20
of them being shared by the two prototypes), on a total of 277
different labels for sequences in IMGT/LIGM-DB, are necessary
and sufﬁcient for a complete description of these prototypes. The
organization of a prototype is based on the relations that order
two labels.
IMGT-ONTOLOGY formalizes the topological relations that
deﬁne the relative position of two labels. A set of twelve relations
arenecessaryandsufﬁcienttodescribetherelationsbetweenlabels
inapr ot otype(Durouxetal.,2008;Laneetal.,2010;Table 2).The
reciprocal relations “is_in_5_prime_of” and “is_in_3_prime_of”
describetherelativepositionof labelsona5 –3  DNAstrandwhen
there is no intersection or contiguity between labels (Lane et al.,
2010).
IMGT® standardized labels in databases and tools
The leafconcepts of description are IMGT® standardized labels
in the databases and tools (Lefranc, 2005). The IMGT®
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FIGURE5|P r o t otype or graphical representation of two
“Molecule_EntityPrototype” leafconcepts. (A) “V-GENE.” (B)
“V-D-J-GENE.”Thirty-nine labels (27 for for “V-GENE” and 33 for
“V-D-J-GENE” of which 20 are shared) and 12 relations are necessary
and sufﬁcient for a complete description of these prototypes (Lefranc,
2011c).
Table 2 | IMGT-ONTOLOGY relations between labels used for the
description of prototypes.
Relation Reciprocal relation
“adjacent_at_its_5_prime_to” “adjacent_at_its_3_prime_to”
“included_with_same_5_prime_in” “includes_with_same_5_prime”
“included_with_same_3_prime_in” “includes_with_same_3_prime”
“overlaps_at_its_5_prime_with” “overlaps_at_its_3_prime_with”
“included_in” “includes”
“is_in_5_prime_of” “is_in_3_prime_of”
standardized labels are available from the IMGT/LIGM-DB
database (Giudicelli et al., 2006) query page (IMGT® Home
page; http://www.imgt.org) and in the IMGT Scientiﬁc chart at:
http://www.imgt.org/IMGTScientiﬁcChart/SequenceDescription/
IMGT3Dkeywords.html (deﬁnitions of these labels are available
at: http://www.imgt.org/IMGTScientiﬁcChart/SequenceDescrip
tion/IMGT3Dlabeldef.html).Morethan560IMGT®standardized
labels(277forsequencesand285for3Dstructures)wereprecisely
deﬁned.
IMGT/Automat, the IMGT® tool for the annotation of
rearranged cDNA (Giudicelli et al., 2005a) implements corre-
sponding labels and prototypes. IMGT® standardized labels and
the organization of “Molecule_EntityPrototype” have recently
been implemented in IMGT/LIGMotif for the automation of the
annotationof largegenomicsequences(Laneetal.,2010).Asetof
speciﬁc labels was deﬁned to describe the different organizations
of IG and TR genes in clusters at the scale of the locus or of the
chromosome.
IMGT-ONTOLOGY CLASSIFICATION AXIOM
TheCLASSIFICATIONaxiomof theFormalIMGT-ONTOLOGY
or IMGT-Kaleidoscope (Duroux et al., 2008) postulates that, for
molecular components, any molecule and its relations have to be
classiﬁed (Lefranc, 2011d). IMGT-ONTOLOGY concepts of clas-
siﬁcation generated from the CLASSIFICATION axiom led to the
IMGT® standardized IG and TR gene and allele nomenclature.
IMGT-ONTOLOGY concepts of classiﬁcation
The IMGT® standardized gene and allele nomenclature is based
ontheconceptsofclassiﬁcation,generatedfromtheCLASSIFICA-
TIONaxiom,whichdeﬁnestheprinciplesforthenomenclatureof
highly polymorphic multigene loci and families. In particular,the
concepts of classiﬁcation have allowed to classify the genes what-
ever the antigen receptor (IG or TR), whatever the locus (e.g., for
mammals, immunoglobulin heavy IGH, immunoglobulin kappa
IGK, immunoglobulin lambda IGL, T cell receptor alpha TRA, T
cell receptor beta TRB, T cell receptor gamma TRG, and T cell
receptor delta TRD), whatever the gene conﬁguration (germline,
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undeﬁned, or rearranged), and whatever the species, from ﬁsh to
human. Among the concepts of classiﬁcation, the “Group,”“Sub-
group,”“Gene,”and“Allele”concepts are essential for the IMGT®
genenomenclature(GiudicelliandLefranc,1999).Theyareshown
with their semantic relations in Figure 6 that are used for the V
gene designation.
IMGT® standardized IG and TR gene and allele nomenclature
Inthecontextofthegeneandalleleclassiﬁcation,ontologicalprin-
ciples deﬁned in IMGT-ONTOLOGY have preceded the IMGT®
standardized gene and allele nomenclature. This has been true for
thehumangenes,andallIMGT®IGandTRgenenames(Lefranc,
2000a,b; Lefranc and Lefranc, 2001a,b)w e r ed e ﬁ n e db e f o r et h e
complete human genome sequencing (Lander et al., 2001; Venter
etal.,2001).Thisisstillthecasefornewlysequencedgenomesand
the denomination of IG and TR genes from a newly sequenced
species is considerably facilitated by the preexisting nomenclature
principles and rules. Full IMGT® standardized gene name com-
prises the latin names of the genus and species (e.g.,Homo sapiens
IGHV1-2). Gene names used in natural language and in pub-
lications may include abbreviation if needed for tables or ﬁgures
(6-lettercodeforgenusandspecies,9-lettercodeforgenus,species,
and subspecies).
Interoperability between IMGT, HGNC, and NCBI
Since the creation of IMGT®, the international ImMunoGeneT-
ics information system® in 1989, at New Haven during the
10th Human Genome Mapping Workshop (HGM10), the stan-
dardized classiﬁcation and nomenclature of the IG and TR
of humans and other vertebrate species have been under the
responsibility of the IMGT Nomenclature Committee (IMGT-
NC). The IMGT® gene nomenclature for human IG and TR
genes (Lefranc, 2000a,b; Lefranc and Lefranc, 2001a,b) was
approvedbytheHumanGenomeOrganisation(HUGO)Nomen-
clature Committee (HGNC) in 1999 (Wain et al., 2002) and
endorsed by the World Health Organization-International Union
of Immunological Societies (WHO-IUIS; Lefranc, 2007, 2008).
IMGT® IG and TR gene names are the ofﬁcial international refer-
enceandhavebeenenteredinIMGT/GENE-DB,theIMGT®gene
database (Giudicelli et al., 2005b), in the Human Genome Data-
base (GDB; Letovsky et al., 1998), in LocusLink at the National
Center for Biotechnology Information (NCBI) in 1999–2000
(Maglott et al., 2000), in NCBI Entrez Gene when this gene data-
base superseded LocusLink (Maglott et al., 2007), in NCBI Gene
and in NCBI MapViewer, in Ensembl at the European Bioin-
formatics Institute (EBI) in 2006 (Hubbard et al., 2002), and in
the Vega Genome Browser at the Wellcome Trust Sanger Insti-
tute (Ashurst et al., 2005). Amino acid sequences of human IG
and TR C genes were provided to UniProt in 2008 (Bairoch et
al., 2009). Close collaborations have been developed to maintain
interoperability between the databases, with HGNC (Wain et al.,
2004; Bruford et al., 2008), NCBI Gene (Maglott et al., 2011),
Ensembl,Vega(Wilmingetal.,2008),theMouseGenomicNomen-
clature Committee (MGNC), the Nomenclature Committees of
newly sequenced genomes, for example, ZFIN for the zebraﬁsh
Danio rerio (Bradford et al., 2011) or external team contribution,
for example, TRB locus of the rhesus macaque Macaca mulatta
(Greenaway et al., 2009). IG and TR genes are also integrated
in the HUGO ontology and NCI Metathesaurus available on the
NCBO BioPortal4. Mapping between the HUGO ontology and
IMGT-ONTOLOGY will be developed with the formalization of
the concepts of classiﬁcation in OWL.
IMGT-ONTOLOGY NUMEROTATION AXIOM
TheNUMEROTATIONaxiomof theFormalIMGT-ONTOLOGY
or IMGT-Kaleidoscope (Duroux et al., 2008) postulates that, for
molecular components, any molecule and its relations have to
be numbered (Lefranc, 2011e,f). Two major IMGT-ONTOLOGY
concepts of numerotation generated from the NUMEROTATION
4http://bioportal.bioontology.org/ontologies/
FIGURE 6 | Concepts of classiﬁcation for gene and allele nomenclature
(generated from the IMGT-ONTOLOGY CLASSIFICATION axiom) (Duroux
et al., 2008; Lefranc, 2011d). (A) Hierarchy of the concepts of classiﬁcation
and their relations (Giudicelli and Lefranc, 1999).The “Locus” concept is a
concept of localization (LOCALIZATION axiom). (B) Example of leafconcepts
for each concept of classiﬁcation.They are associated with a “TaxonRank”
level, and more precisely for the “Gene” and “Allele” concepts with a
leafconcept of “Species” (here, Homo sapiens).
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axiom comprises the “IMGT_unique_numbering” and “IMGT_
Collier_de_Perles”(IMGT unique numbering and IMGT Colliers
de Perles in IMGT® databases and tools).
“IMGT_unique_numbering”
The “IMGT_unique_numbering” concept (Lefranc, 2011e)
deﬁnes a systematic and coherent numbering (amino acids and
codons) for the description of “DomainType” leafconcepts. The
“IMGT_unique_numbering” was originally deﬁned for the IG
and TR V-DOMAIN (Lefranc, 1997). It provides a standardized
delimitation of the framework regions (FR-IMGT) and com-
plementarity determining regions (CDR-IMGT), and therefore
allows to correlate each position (amino acid or codon) with the
structure (beta strand, loop, beta turn) and the function (antigen
binding) of the V-DOMAIN. FR-IMGT and CDR-IMGT lengths
became a major property of the IG and TR V-DOMAIN. The
“IMGT_unique_numbering” concept has been extended to the
V-LIKE-DOMAIN of the IgSF other than IG and TR (Lefranc,
1999; Lefranc et al., 2003), to the C domain (C-DOMAIN of
IG and TR and C-LIKE-DOMAIN of IgSF other than IG and
TR; Lefranc et al., 2005b) and to the G domain (G-DOMAIN
of MH and G-LIKE-DOMAIN of MhSF other than MH)
(Lefranc et al., 2005c). Thus, the “IMGT_unique_numbering”
concept allows to number domain types that are character-
istic of protein superfamilies, whatever the species, the mol-
ecule type or the chain type. Three leafconcepts have been
deﬁned for the variable (V) domain, the constant (C) domain,
and the groove (G) domain: “IMGT_unique_numbering_
for_V_domain” (Lefranc, 1997, 1999; Lefranc et al., 2003)
and “IMGT_unique_numbering_for_C_domain” (Lefranc et al.,
2005b) of the IG, TR and IgSF, and“IMGT_unique_numbering_
for_G_domain”(Lefranc et al.,2005c) of the MH and MhSF.
“IMGT_Collier_de_Perles”
The “IMGT_Collier_de_Perles” concept (Lefranc, 2011f)c o r r e -
sponds to the graphical 2D representation of domains based on
the set of rules deﬁned by the “IMGT_unique_numbering.” This
originalanduniqueapproachallowsonetobridgethegapbetween
sequences and 2D and 3D structures and greatly facilitates the
domain comparison, position per position. Three leafconcepts
are deﬁned: “IMGT_Collier_de_Perles for_V_domain” (Lefranc,
1999; Lefranc et al., 2003), “IMGT_Collier_de_Perles_for_C_
domain” (Lefranc et al., 2005b) and “IMGT_Collier_de_Perles
for_G_domain”(Lefranc et al.,2005c).
Figure 7 shows graphical representations of “IMGT_Collier_
de_Perles_for_V_domain” (Lefranc et al., 2003). The ﬁve highly
conserved amino acids found in IG and TR V domains, whatever
the species and molecule type, are highlighted (online in red let-
ters): at position 23 (1st-CYS, or ﬁrst conserved cysteine C), 41
(CONSERVED-TRP,orconservedtryptophanW),89(hydropho-
bic amino acid, here methionine M), 104 (2nd-CYS, or second
conserved cysteine C), and 118 (here J-PHE, or J-REGION tryp-
tophan W). This leafconcept allows, for the ﬁrst time, to compare
domains of IG and TR (V-DOMAIN) and of IgSF proteins other
thanIGorTR(V-LIKE-DOMAIN),ononelayer(facilitatingcom-
parison with sequences) or on two layers (bridging comparison
with 3D structures).
Figure 8 shows graphical representations of “IMGT_Collier_
de_Perles_for_G_domain” (Lefranc et al., 2005c). This leafcon-
cept allows, for the ﬁrst time, to compare domains of the same
chain (G-ALPHA1 and G-ALPHA2 of MH1), domains of differ-
entchainsof thesamereceptor(G-ALPHAandG-BETAof MH2),
or domains of MhSF proteins other than MH (G-ALPHA1-LIKE
and G-ALPHA2-LIKE of RPI-MH1Like).
IMGT unique numbering and IMGT Collier de Perles in databases
and tools
The IMGT unique numbering and the IMGT Colliers de Perles
are used for the numbering of both the codons (in nucleotide
sequences) and the amino acids (in protein sequences and struc-
tures;RuizandLefranc,2002;GarapatiandLefranc,2007;Kaasand
Lefranc,2007; Kaas et al.,2007). By facilitating the comparison of
residuesbetweensequences,theIMGTuniquenumberingandthe
IMGT Colliers de Perles have been the basis for the description of
theIGandTRgeneallelicpolymorphismandforthestudiesof IG
somatic hypermutations in V-DOMAIN. They represent a major
breakthrough for the analysis and the comparison of the huge
repertoires of antigen receptors (potentially 2×1012 per individ-
ual).Indeed,theIMGTuniquenumberingandtheIMGTColliers
dePerlesrepresentakeycomponentinimmunogeneticsstudiesby
creatingastrongandreliableinteroperabilitybetweentheIMGT®
databases, tools, and web resources (Lefranc et al.,2009).
Rules for the IMGT unique numbering are implemented in
IMGT® online tools: for the analysis of IG and TR rearranged
cDNA sequences by IMGT/V-QUEST (Brochet et al., 2008; Giu-
dicelli et al., 2011) and IMGT/JunctionAnalysis (Yousﬁ Monod
et al., 2004; Bleakley et al., 2006; Giudicelli and Lefranc, 2011),
for the analysis of cDNA sequences from high-throughput NGS
sequencing by IMGT/HighV-QUEST (Alamyar et al., 2012) and
for the analysis of amino acid sequences and 2D structures
by IMGT/DomainGapAlign (Ehrenmann and Lefranc, 2011a),
IMGT/DomainDisplay and IMGT/Collier-de-Perles (Ehrenmann
et al.,2011). They are also implemented in IMGT® databases,and
particularly in IMGT/3Dstructure-DB (Ehrenmann et al., 2010a;
Ehrenmann and Lefranc, 2011b) where they have been funda-
mental in the setting up of the standardized deﬁnition of contact
analysis (Kaas and Lefranc, 2005; Kaas et al., 2008; Ehrenmann
et al., 2010a) and of paratope and epitope in crystal structures
(Lefranc, 2009; Ehrenmann et al.,2010b).
The IMGT Colliers de Perles are particularly useful in molecu-
lar engineering and antibody humanization design based on CDR
grafting. Indeed they allow to precisely deﬁne the CDR-IMGT
and to easily compare the amino acid sequences of FR-IMGT
and CDR-IMGT between the mouse (or other species) and the
closest human V-DOMAIN (Lefranc, 2009; Ehrenmann et al.,
2010b). Analyses performed on humanized therapeutic antibod-
ies underline the importance of a correct delimitation of the
CDR regions to be grafted (Magdelaine-Beuzelin et al., 2007).
The IMGT Colliers de Perles also allow a comparison to the
IMGTColliersdePerlesstatisticalproﬁlesforthehumanexpressed
IGHV, IGKV, and IGLV repertoires. These statistical proﬁles are
based on the deﬁnition of 11 IMGT amino acid physicochemi-
cal characteristics classes which take into account the hydropa-
thy, volume, and chemical characteristics of the 20 common
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FIGURE 7 | IMGT Collier de Perles forV domain. (A) Ribbon
representation of aV-DOMAIN as an example. A similar topology and 3D
structure characterize a V-LIKE-DOMAIN. (B) and (C) V-DOMAIN on one layer
and on two layers, respectively (Mus musculus VH [8.8.12]). (D)
V-LIKE-DOMAIN on two layers (Homo sapiens CD28 [9.9.13]). Amino acids
are shown in the one-letter abbreviation. Positions at which hydrophobic
amino acids (hydropathy index with positive value: I, V, L, F , C, M, A) and
tryptophan (W) are found in more than 50% of analyzed sequences are
shown online in blue. All proline (P) are shown online in yellow.The loops BC,
C
 C
   and FG (corresponding to the CDR-IMGT) are limited by amino acids
shown in squares (anchor positions), which belong to the neighboring strands
(FR-IMGT). BC loops are represented online in red, C
 C
   loops in orange and
FG loops in purple. Hatched circles or squares correspond to missing
positions according to the IMGT unique numbering for V domain (Lefranc
et al., 2003). Arrows indicate the direction of the beta strands and their
designations in 3D structures.The IMGT Colliers de Perles on two layers
show, in the forefront, the GFCC
 C
   strands and, in the back, the ABED
strands.The chain identiﬁers to which the domains belong are 1a3l_H for (A),
(B), (C), and 1yjd_C for (D) [IMGT/3Dstructure-DB (Ehrenmann et al., 2010a;
Ehrenmann and Lefranc, 2011b)].
amino acids (Pommié et al., 2004). This comparison is useful
to identify potential immunogenic residues at given positions in
chimericorhumanizedantibodiesortoevaluateimmunogenicity
of therapeutic antibodies.
DISCUSSION
The standardization, the consistency and the reliability of the
immunogenetics data in IMGT®, the international ImMuno-
GeneTics information system® (http://www.imgt.org) rely on
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FIGURE 8 | IMGT Collier de Perles for G domain. (A) Ribbon
representation of two G-DOMAIN as an example. A similar topology and
3D structure characterize the G-LIKE-DOMAIN. (B) G-DOMAIN of MH1:
G-ALPHA1 and G-ALPHA2 (Homo sapiens HLA-A∗0201). (C) G-DOMAIN
of MH2: G-ALPHA and G-BETA (Homo sapiens HLA-DRA∗0101 and
HLA-DRB1∗0101). (D) G-LIKE-DOMAIN of RPI-MH1Like: G-ALPHA1-LIKE
and G-ALPHA2-LIKE (Mus musculus CD1D1). Amino acids are shown in
the one-letter abbreviation. Hatched circles correspond to missing
positions according to the IMGT unique numbering for G domain (Lefranc
et al., 2005c). Note that the N-terminal end of a peptide in the cleft would
be on the left hand side.The chain identiﬁers to which the domains belong
are 1akj_A for (A) and (B), 1fyt_B for (C) and 1cd1_C for (D)
[IMGT/3Dstructure-DB (Ehrenmann et al., 2010a; Ehrenmann and Lefranc,
2011b)].
IMGT-ONTOLOGY, elaborated since 1989 in order to manage,
to share and to represent the immunogenetics knowledge (Giudi-
celli and Lefranc, 1999; Lefranc et al., 2004, 2005a; 2008; Duroux
et al.,2008; Lefranc, 2011a,b,c,d,e,f, 2013).
IMGT-ONTOLOGY has been developed to be used by any sci-
entiﬁc domain which deals with immunogenetics. This includes
fundamental, medical, veterinary, clinical, pharmaceutical and
biotechnological research. Closely related terms have been inte-
grated in some other biological ontologies (Table 3). Chain types
have been included in NCI Thesaurus, Logical Observation Iden-
tiﬁer Names and Codes (LOINC), Molecule role (INOH Protein
name/familynameontology)(IMR),NationalDrugFileReference
Terminology (NDRFT). IMGT® standardized labels that describe
speciﬁcally IG and TR sequences and 3D structures and 64 of
the IMGT® standardized labels, in particular those for genomic
sequences, have been included in Sequence Ontology (SO; Eil-
beck et al., 2005) and in SNP-Ontology. IG and TR gene names
were entered in HUGO and NCI Metathesaurus (Table 3). These
ontologiesareavailableontheNCBOBioPortal(Noyetal.,2009),
opening opportunities of mapping with them.
IMGT® standards derived from IMGT-ONTOLOGY concepts
allow interoperability between external databases and tools. Inter-
operability between IMGT®, HGNC, NCBI, Ensembl, and Vega
for the concepts of classiﬁcation has been described (see Inter-
operability between IMGT, HGNC, and NCBI). The IMGT num-
bering is integrated in external Web resources: it is proposed, for
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T a b l e3|F o r m a lIMGT-ONTOLOGY axioms, IMGT-ONTOLOGY concepts, IMGT® standards, and external resources.
Formal IMGT-
ONTOLOGY axioms
IDENTIFICATION DESCRIPTION CLASSIFICATION NUMEROTATION
IMGT-ONTOLOGY
conceptsa
Concepts of identiﬁcationb (/1491) Concepts of
descriptionc
Concepts of
classiﬁcationd
Concepts of numerotatione,f
IMGT® standards IMGT® standardized keywords IMGT® standardized
labels
IMGT® standardized IG
andTR gene names
IMGT unique numbering
IMGT Colliers de Perles
External resources
(ontologies, databases,
and tools)
NCIThesaurus (/1032) Sequence types and
features (SO) (/1109)
HUGO (/1528) IgBlast
Logical Observation Identiﬁer Names
and Codes (LOINC) (/1350)
SNP-Ontology (/1058) NCI Metathesaurus
(/1499)
Molecule role (INOH Protein name/
family name ontology) (IMR) (/1029)
HGNC (Bruford et al.,
2008)
National Drug File Reference
Terminology (NDRFT) (/1352)
NCBI gene (Maglott
et al., 2011)
Ensembl (Hubbard
et al., 2002)
Vega (Wilming et al.,
2008)
(/number) indicates, for ontologies at NCBO BioPortal, the identiﬁant to be added to http://bioportal.bioontology.org/ontologies.
aGiudicelli and Lefranc (1999), Lefranc et al. (2004, 2005a, 2008), Duroux et al. (2008), Lefranc (2013).
b–fLefranc (2011b,c,d,e,f).
example, as domain system numbering in the sequence analysis
tool IgBlast5.
The IMGT® standards generated from IMGT-ONTOLOGY
are extensively reused by scientists in very diverse domains for
the interpretation of immunogenetics data. The ﬁrst example is
the acknowledgment of the IMGT® gene names as the ofﬁcial
nomenclature for IG and TR genes (Wain et al., 2002; Lefranc,
2007,2008),referencedandrecordedingenomesites(NCBIGene;
Maglott et al., 2011). The second example concerns the medical
and clinical research which requires a high level of standardiza-
tion for the results of data analysis in order to take therapeutical
decisions: the European Research Initiative on chronic lympho-
cytic leukemia (CLL) (ERIC) includes 130 laboratories in 26
countries. ERIC has recommended the use of IMGT/V-QUEST
(Brochet et al., 2008; Giudicelli et al., 2011), the IMGT® tool
for the analysis of IG and TR rearranged sequences, as a ref-
erence for determining the rate of IGHV gene mutations, an
important prognostic factor for CLL patients (Ghia et al., 2007;
Giudicelli and Lefranc, 2008; Langerak et al., 2011). Results pro-
vided with the IMGT® standards are integrated in clinical reports
(Rosenquist, 2008). The third example is the deﬁnition of mon-
oclonal antibodies (mAb, sufﬁx -mab) and fusion proteins for
immune applications (FPIA, sufﬁx -cept) of the World Health
Organization/International Nonproprietary Name (WHO/INN)
programme that are based on the IMGT-ONTOLOGY concepts
(Lefranc, 2011g). INN mAb and FPIA have been entered in
IMGT/mAb-DB and IMGT/2Dstructure-DB, allowing queries of
sequences, 2D structures (or IMGT Collier de Perles) and, if
available, 3D structures. The fourth example of great interest
5http://www.ncbi.nlm.nih.gov/igblast/
for pharmaceutical companies involved in antibody engineer-
ing and humanization for therapeutical use is the characteriza-
tion of the three hypervariable loops (or CDR-IMGT) of an IG
or TR variable domain using the IMGT/DomainGapAlign and
IMGT/Collier-de-Perles tools. The objective of antibody human-
ization is to graft the CDR-IMGT of an antibody, usually murine,
and of a given speciﬁcity onto a human domain framework,
thus preserving the original murine antibody speciﬁcity while
decreasing its immunogenicity (Lefranc, 2009; Ehrenmann et al.,
2010b).
IMGT-ONTOLOGY and IMGT® standards ensure the
coherency of the IMGT® information system whose data per-
manently evolve with the most recent advances in science and
methodologies. They form a unique and necessary whole for the
modeling, the representation and the sharing of the immuno-
genetics knowledge by both humans and automated resources.
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